Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC By Ogkologos - July 14, 2025 569 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IMforte study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR What Survivors Should Know When Transitioning From Cancer Care to Primary... April 4, 2023 Lack of Evidence for the Use of Telemedicine in the Prevention... September 13, 2021 FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο February 22, 2020 Idecabtagene Vicleucel Prolongs PFS and Improves Response Compared with Standard Regimens... February 23, 2023 Load more HOT NEWS Working Together to Choose a Cancer Treatment Plan: A Caregiver’s Perspective Prostate cancer: Lessons Learned from My Breast Cancer Studying Molecular Subtypes of Peritoneal Metastases in Gastric Cancer ΚΑΡΚΙΝΟΣ ΠΑΓΚΡΕΑΤΟΣ
